Clin2
NCT07598981Likely a fitRecruiting

Obesity Medication Safety and Effectiveness Registry

Obesity

Part of Hormones & metabolism clinical trials.

This registry tracks how well obesity medications work and their safety in real-world use. You'll share your health information and experiences with your obesity medication over time to help doctors understand what works best for different people.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You are starting an obesity medication for the first time (or considering starting one)
  • You do not have Type 2 diabetes
  • You can complete forms online using your personal device (computer or phone)
  • You are willing to provide your name, email, and location information
  • You are not enrolled in a blinded clinical trial (where you don't know if you're getting the real treatment)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07472608Not yet recruiting
Obesity medicine bank study at Quebec Heart and Lung Institute

This study collects medical information and biological samples from people with obesity or related weight issues to better understand and treat obesity. You may qualify if you are referred to the bariatric clinic and meet one of several weight-related criteria.

Québec, Quebec
NCT07640139Enrolling by invitation
Study of Weight-Loss Medications' Health and Cost Effects

This research study looks at how obesity medications affect people's health outcomes and healthcare costs. Researchers will track employees and their family members covered by participating Indiana employers to understand whether these medications help improve conditions like diabetes and heart health.

Indianapolis, Indiana
NCT07142707Recruiting· Phase 1
Testing a new obesity drug for safety and effects

This study tests an investigational medication called MBX 4291 for adults with obesity. It aims to see if the drug is safe and how it works in the body, which could lead to a new weight-loss treatment option.

Doral, Florida
NCT07731139Not yet recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07041983Enrolling by invitation
Measuring energy use in obesity treatment

This study looks at how certain anti-obesity medications affect your body's energy use over 24 hours to help you lose weight more effectively.

Pisa
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.